Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Skin fibroblasts from a D-deletion type retinoblastoma patient are abnormally X-ray sensitive

Abstract

RETINOBLASTOMA is a rare malignant eye tumour which appears spontaneously or occurs in genetically predisposed persons1–3. The latter group is composed of patients who inherit the tumour with a dominant mode of transmission (80–90% penetrance) (referred to as the familial type) or those who bear a deletion in the long arm of chromosome 13 (13q-) (referred to as the D-deletion type). When this deletion is present, it is observed in many somatic cells and is often associated with structural defects such as microcephaly, micropthalmia and several skeletal and genitourinary abnormalities3,4. Survivors of the genetic forms of retinoblastoma have an increased risk for the development of cancers at other sites, while patients who survive the sporadic type do not2–6. A single genetic locus is unlikely to predispose many somatic cells to tumour formation unless a fundamental molecular defect—for example, related to DNA repair—is present. To investigate this hypothesis, we have examined the in vitro X-ray sensitivity of skin fibroblast strains derived from three retinoblastoma patients—a pair of twins with the familial type accompanied by no gross chromosome abnormalities, and a patient with the D-deletion type. We also used two normal fibroblast strains and a strain from a patient with ataxia telangiectasia. We found that the strain derived from the D-deletion retinoblastoma patient was significantly more radiosensitive than the two normal strains, but not as sensitive as that from the ataxia patient.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Knudson, A. G. Proc. natn. Acad. Sci. U.S.A. 68, 820–823 (1971).

    Article  ADS  Google Scholar 

  2. Lancet ii, 1016–1017 (1971).

  3. Knudson, A. G., Meadows, A. T., Nichols, W. W. & Hill, R. New Engl. J. Med. 295, 1120–1123 (1976).

    Article  Google Scholar 

  4. Francke, U. Cytogenet. Cell Genet. 16, 131–134 (1976).

    Article  CAS  Google Scholar 

  5. Strong, L. C. & Knudson, A. G. Lancet ii, 1086 (1973).

  6. Jensen, R. D. & Miller, R. W. New Engl. J. Med. 285, 307–311 (1971).

    Article  CAS  Google Scholar 

  7. Taylor, A. M. R. et al. Nature 258, 427–429 (1975).

    Article  ADS  CAS  Google Scholar 

  8. Paterson, M. C., Smith, B. P., Lohman, P. H. M., Anderson, A. K. & Fishman, L. Nature 260, 444–447 (1976).

    Article  ADS  CAS  Google Scholar 

  9. Weichselbaum, R., Epstein, J. & Little, J. B. Radiology 121, 479–482 (1976).

    Article  CAS  Google Scholar 

  10. Cleaver, J. Nature 218, 652–656 (1968).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

WEICHSELBAUM, R., NOVE, J. & LITTLE, J. Skin fibroblasts from a D-deletion type retinoblastoma patient are abnormally X-ray sensitive. Nature 266, 726–727 (1977). https://doi.org/10.1038/266726a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/266726a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing